Last reviewed · How we verify
NCT03396549
Effect of tDCS Montage on Measures of Appetite
NA trial testing new sham tDCS in Eating Behavior in 28 participants. Completed in 14 March 2018.
14 March 2018
Quick facts
| Lead sponsor | University of Alabama at Birmingham |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | single group |
| Masking | double |
| Primary purpose | basic science |
| Enrollment | 28 |
| Start date | 7 March 2018 |
| Primary completion | 14 March 2018 |
| Estimated completion | 14 March 2018 |
| Sites | 1 location across United States |
Drugs / interventions tested
- new sham tDCS
- real tDCS
Conditions studied
- Eating Behavior — all drugs for Eating Behavior →
Sponsor
University of Alabama at Birmingham
Who can join
Adults 18 to 55, any sex, with Eating Behavior. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim is to validate a new sham (control) method for use in transcranial direct current stimulation (tDCS) that is less discernible to participants from the real condition. Participants are often able to tell real from sham conditions. Correctly guessing real from sham undermines the integrity of evaluations of the value of tDCS as a treatment tool as responses may be in part or entirely the result of treatment expectation effects. The study will test a new sham method to reduce food craving and eating and test how much participants are able to discern it from the real or 'target' condition.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03396549
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Eating Behavior
Currently open trials in the same condition.
- NCT06551974 — INTERconNEcT-Eds: a Guided Self-help Mobile App to Improve Outcome in Eating Disorders · NA · recruiting
- NCT07348432 — The diabEAT Study: Insulin dElivery Technologies And eaTing Behaviours in People With Type 1 Diabetes · recruiting
- NCT06175988 — Visceral Adiposity, Vagal Tone and Food Preferences: a Pilot Study · recruiting
- NCT06145009 — Time Restricted Eating, Eating Behaviors, and Cardiometabolic Risk in Emerging Adult Women · NA · recruiting
- NCT06108128 — Food for Thought: Executive Functioning Around Eating Among Children · NA · recruiting
Other University of Alabama at Birmingham trials
Trials by the same sponsor.
- NCT04922229 — Comparative Effectiveness in the Management of Irreversible Pulpitis · NA · not yet recruiting
- NCT05060380 — Feasibility of a Novel Resistance Exercise in Individuals With Osteoporosis · NA · withdrawn
- NCT04768777 — Behavioral Intervention for Physical Activity and Sexual Dysfunction in Multiple Sclerosis · NA · not yet recruiting
- NCT06320951 — VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine · Phase 2 · not yet recruiting
- NCT07564934 — Leveraging Extended Reality Exergaming and Telehealth to Improve Physical Activity and Health in Children With Disabilit · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03396549 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Alabama at Birmingham
- Last refreshed: 15 May 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03396549.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing